DigestRedComo funciona
Red
/
Empresas
Ru
No verificado

Rubedo Life Sciences, Inc.

Sobre qué escribimos

BiotecnologíaIndustriaMedicina - VariosSaludTécnica

5 Comunicados de prensa

Ver todos los comunicados de prensa
26/03/2026
Eventos
Industria
Sanidad
Software
Oncología
Técnica
Medicina - Varios
Ciencia
Biotecnología
Salud
Rubedo Life Sciences Announces Positive Preliminary Phase 1 Clinical Trial Results for Lead Drug Candidate RLS-1496 in Patients with Plaque Psoriasis, Atopic Dermatitis, and Skin Aging
Fuente
Rubedo Life Sciences, Inc.
Editor
Business Wire
1.00
0
30/10/2025
Rubedo Life Sciences and SVAX Announce Strategic Partnership During FII Week in Riyadh
Fuente
Rubedo Life Sciences, Inc.
Editor
Business Wire
1.00
0
17/09/2025
Técnica
Higiene alimentaria
Medicina - Varios
Biotecnología
Salud
Farmacéutica
Oncología
Mercado laboral
Industria
Rubedo Life Sciences Announces U.S. FDA Clearance of IND for Selective GPX4 Modulating Lead Drug Candidate RLS-1496 for Actinic Keratosis, Expands Clinical Advisory Board
Fuente
Rubedo Life Sciences, Inc.
Editor
Business Wire
1.00
0
22/05/2025
Industria
Biotecnología
Farmacéutica
Salud
Técnica
Medicina - Varios
Rubedo Life Sciences Announces First Patient Dosed with Lead Drug Candidate RLS-1496, the First GPX4 Modulator Targeting Pathologic Senescent Cells To Enter Phase 1 Clinical Trial
Fuente
Rubedo Life Sciences, Inc.
Editor
Business Wire
1.00
0
15/05/2025
Rubedo Life Sciences’ Drug Discovery Platform, ALEMBIC™, Helps Identify Senescent or “Zombie” Neurons in New Study Linking Neuropathic Pain and Aging Published in Peer-Reviewed Scientific Journal Nature Neuroscience
Fuente
Rubedo Life Sciences, Inc.
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0